| P2093 | author name string | Hua Peng | |
| | Yan Li | |
| | Xuehui Chen | |
| | Meng Cao | |
| | Jie Hai | |
| | Lake Li | |
| | Qinggui Zhang | |
| P2860 | cites work | Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion | Q21144322 |
| | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| | Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways | Q24647705 |
| | Caspases: opening the boxes and interpreting the arrows | Q28216089 |
| | Apoptosis and cancer: mutations within caspase genes | Q28247775 |
| | Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ | Q28248705 |
| | AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes | Q28369312 |
| | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 |
| | Inflammation in nonalcoholic steatohepatitis | Q30453231 |
| | Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans | Q30496263 |
| | Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats | Q33779364 |
| | Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery | Q33959262 |
| | Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis | Q34433803 |
| | Therapeutic action of ghrelin in a mouse model of colitis. | Q34525422 |
| | Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | Q34830398 |
| | Ghrelin in the regulation of body weight and metabolism | Q35011714 |
| | From fat to inflammation | Q36364153 |
| | The current state of serum biomarkers of hepatotoxicity. | Q37091307 |
| | Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications | Q37863133 |
| | The role of oxidative stress in non-alcoholic steatohepatitis | Q37868177 |
| | Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role | Q37887977 |
| | Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice | Q38342226 |
| | The natural history of nonalcoholic fatty liver: a follow-up study | Q40376691 |
| | Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade | Q42160057 |
| | Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice | Q42909043 |
| | Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans | Q43193400 |
| | In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases | Q44036833 |
| | Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes | Q44599802 |
| | Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis | Q45016055 |
| | The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years | Q45787554 |
| | Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats | Q46989966 |
| | Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. | Q53252814 |
| | Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. | Q54465650 |
| | Ghrelin ameliorates TNF-a induced anti-proliferative and pro-apoptotic effects and promotes intestinal epithelial restitution | Q56430877 |
| | Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation | Q71832696 |
| | Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 |
| | Nonalcoholic steatohepatitis | Q74424858 |
| | Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats | Q79911296 |
| | Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats | Q80023470 |
| | Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria | Q81394952 |
| | Hepatoprotective effect of ghrelin on carbon tetrachloride-induced acute liver injury in rats | Q84273091 |
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| | liver disease | Q929737 |
| | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| | non-alcoholic fatty liver | Q66299798 |
| P304 | page(s) | 376-386 | |
| P577 | publication date | 2012-07-29 | |
| P1433 | published in | Endocrine | Q15757048 |
| P1476 | title | Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development | |
| P478 | volume | 43 | |